A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study protocol for a randomized controlled, non-inferiority trial

BACKGROUND: The gonadotropin-releasing hormone (GnRH) antagonist protocol is advantageous given that it can avoid severe ovarian hyperstimulation syndrome (OHSS), especially for patients with polycystic ovary syndrome (PCOS). Basic and clinical evidence has shown that a threshold of luteinizing horm...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shan, Lv, Ya-su, Han, Shuo, Liu, Minghui, Ma, Shuai, Ren, Haiying, Li, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375259/
https://www.ncbi.nlm.nih.gov/pubmed/35964041
http://dx.doi.org/10.1186/s13063-022-06586-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375259/
https://www.ncbi.nlm.nih.gov/pubmed/35964041
http://dx.doi.org/10.1186/s13063-022-06586-1

Ejemplares similares